Acquisition leverage Velosity’s acquisition of Lucid Labs and addition of a chief innovation officer signals an expanded design and development capability. Use this to position combined design-to-manufacturing solutions for medical device OEMs seeking integrated product development and faster time to market.

Lab and center The opening of Velosity Lab and expansion of a 100,000 ft² machining center in Brooklyn Park demonstrates a strong in-house prototyping and precision machining footprint. Target emerging startups and midsize OEMs needing rapid prototyping, validation, and scale-ready manufacturing.

Quality leadership Awards for workplace safety and Gold Achievement in incident rates highlight a proven safety and quality culture. Sell to risk-averse manufacturers prioritizing compliant, reliable production environments and favorable industrial automation and operability metrics.

Full stack Velosity emphasizes end-to-end capabilities across design, engineering, tooling and precision manufacturing. Present opportunities to OEMs seeking a single vetted partner to reduce program risk, supplier complexity, and time to market.

Growth trajectory Recent investments in assets, expansion of facilities, and strategic hires indicate a growth-focused roadmap. Propose scalable contracts, expand current engagements, and introduce maintenance, retraining, and upgrade programs to capture long-term commercial opportunities.